Correlation between neuropsychological tests and hypoperfusion in MCI patients: Anatomical labeling using xj view and talairach daemon software

Annals of Nuclear Medicine

Volumn 26, Issue 8, 2012, Pages 656-664

  Yoon, Hyun Jin ^a   Park, Kyung Won ^a   Jeong, Young Jin ^a   Kang, Do Young ^a  

^a Dong A University   (South Korea)

Author keywords

Hypoperfusion; Mild cognitive impairment (MCI); Neuropsychological tests; SPECT; SPM8; XjView

Indexed keywords

AGED; ARTICLE; BRAIN PERFUSION; BRAIN REGION; CINGULATE GYRUS; COMPLEMENT FIXATION TEST; COMPUTER PROGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUSIFORM GYRUS; HUMAN; INFERIOR FRONTAL GYRUS; LEARNING; LINGUAL GYRUS; MAJOR CLINICAL STUDY; MALE; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARAHIPPOCAMPAL GYRUS; POSTCENTRAL GYRUS; PRIORITY JOURNAL; RECALL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPERIOR TEMPORAL GYRUS; THALAMUS;

AGED; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; REGIONAL BLOOD FLOW; SOFTWARE; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84867989034     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-012-0625-0     Document Type: Article

References (48)

1. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia. Mov Disord. 2006;21(9):1343-9. (Pubitemid 44613283)
2. Kim JW, Jo HY, Park MJ, Cheon SM. Mild cognitive impairment in Parkinson's disease. J Mov Disord. 2008;1(1):19-25.
3. Kim JW, Cheon SM, Park MJ, Kim SY, Jo HY. Cognitive impairment in Parkinson's disease without dementia: subtypes and influences of age. J Clin Neurol. 2009;133-8.
4. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985-92.
5. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol. 1999;56(3):303-8. (Pubitemid 29120227)
6. Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, et al. Combined 99m Tc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging. 2006;27(1):24-31. (Pubitemid 41627946)
7. Kang HJ, Kang EJ, Lee JS, Yeo JS, Kim JY, Lee DS, et al. Relationship between brain perfusion SPECT and MMSE Score in dementia of Alzheimer's type: A statistical parametric mapping analysis. Korean J Nucl Med. 2002;36(2):91-101.
8. Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology. 2006; 67(7):1201-7. (Pubitemid 44563828)
9. Matsuda H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med. 2007;48(8): 1289-300. (Pubitemid 47242794)
10. Herholz K, Schopphoff H, Schmidt M, Mielke R, Eschner W, Scheidhauer K, et al. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. J Nucl Med. 2002;43(1):21-6. (Pubitemid 34101183)
11. Bradley KM. Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease. Brain. 2002;125(8): 1772-81.
12. Habert MO. Brain perfusion SPECT correlates with CSF biomarkers in Alzheimer's disease. Eur J Nucl Med. 2010;37(3): 589-93.
13. Petersen R. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-94. (Pubitemid 39222988)
14. Nobili F,AbbruzzeseG, Morbelli S, MarcheseR, Girtler N, DessiB, et al.Amnestic mild cognitive impairment in Parkinson's disease: A brain perfusion SPECT study. Mov Disord. 2009;24(3):414-21.
15. Kang YW, Na DL, Hahn SH. A validity study on the Korean Mini-Mental State Examination (MMSE) in dementia patients. J Korean Neurol Assoc. 1997;15:300-7.
16. Kang Y, Na D. Seoul neuropsychological screening battery. Incheon: Human Brain Research & Consulting Co; 2003.
17. Chang L. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25(1):638-43.
18. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp. 1994;2(4):189-210. (Pubitemid 124008664)
19. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Hum Brain Mapp. 1995;3(3):165-89. (Pubitemid 3036540)
20. Friston K, Holmes A, Poline J, Price C, Frith C. Detecting activations in PET and fMRI: Levels of inference and power. Neuroimage. 1996;4(3):223-35.
21. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme; 1988.
22. SPM8. http://www.fil.ion.ucl.ac.uk/spm/software/spm8. Accessed 1 July 2010.
23. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 2000;10(3):120-31. (Pubitemid 30456920)
24. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, et al. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage. 2005;25(4):1325-35. (Pubitemid 40591672)
25. Morbelli S, Rodriguez G, Mignone A, Altrinetti V, Brugnolo A, Piccardo A, et al. The need of appropriate brain SPECT templates for SPM comparisons. Q J Nucl Med Mol Imaging. 2008;52(1):89-98. (Pubitemid 351351048)
26. xjView. http://www.alivelearn.net/xjview8/Accessed 8 May 2010.
27. Talairach Daemon 2.4.2. http://www.talairach.org/Accessed 8 May 2010.
28. Lee JS, Lee DS, Oh SH, Kim CS, Kim JW, Hwang CH, et al. PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness. J Nucl Med. 2003;44(9):1435-9.
29. Benoit M, Clairet S, Koulibaly P, Darcourt J, Robert P. Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease. Int J Geriatr Psychiatry. 2004;19(9):864-9. (Pubitemid 39242892)
30. Benoit M, Dygai I, Migneco O, Robert P, Bertogliati C, Darcourt J, et al. Behavioral and psychological symptoms in Alzheimer's disease. Dement Geriatr Cogn Disord. 2000;10(6):511-7.
31. Migneco O, Benoit M, Koulibaly PM, Dygai I, Bertogliati C, Desvignes P, et al. Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: A study in Alzheimer's disease and nondemented patients. Neuroimage. 2001;13(5):896-902. (Pubitemid 32848334)
32. Kang JH, Cheon SM, Park JW, Cha JK, Kim SH, Kang DY, et al. Analysis of regional cerebral blood flow using brain SPECT in the patients with mild cognitive impairment according to subtypes. Dement Neurocognitive Disord. 2009;8:21-7.
33. MNI Space Utility. http://www.ihb.spb.ru/.pet-lab/MSU/MSUMain.html
34. WFU PickAtlas. http://www.fmri.wfubmc.edu/cms/software Accessed 1 July 2010.
35. CBU Imaging. http://imaging.mrc-cbu.cam.ac.uk/imaging/CbuImaging Accessed 1 July 2010.
36. Lancaster J, Summerlin J, Rainey L, Freitas C, Fox P. The Talairach daemon, a database server for Talairach atlas labels. Neuroimage. 1997;5(4):238-42.
37. Maldjian J, Laurienti P, Kraft R, Burdette J. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19(3):1233-9. (Pubitemid 36918259)
38. Caroli A, Testa C, Geroldi C, Nobili F, Barnden LR, Guerra UP, et al. Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment. J Neurol. 2007;254(12):1698-707.
39. Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. NeuroReport. 2002; 13(15):1939-43. (Pubitemid 35398965)
40. Encinas M, Juan R, Marcos A, Gil P, Barabash A, Fernandez C, et al. Regional cerebral blood flow assessed with 99m Tc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2003; 30(11):1473-80. (Pubitemid 37356114)
41. Chételat G, Eustache F, Viader F, De La Sayette V, Pélerin A, Mézenge F, et al. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase. 2005;11(1):14-25. (Pubitemid 40372856)
42. Ishiwata A, Sakayori O, Minoshima S, Mizumura S, Kitamura S, Katayama Y. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: A qualitative and quantitative SPECT study. Acta Neurol Scand. 2006;114(2):91-6. (Pubitemid 44034255)
43. Drzezga A, Grimmer T, Riemenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET. J Nucl Med. 2005;46(10):1625-32. (Pubitemid 46211586)
44. Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, et al. Reduced hippocampal metabolism in MCI and AD: Automated FDG-PET image analysis. Neurology. 2005;64(11): 1860-7. (Pubitemid 40800698)
45. Johnson K, Moran E, Becker J, Blacker D, Fischman A, Albert M. Single photon emission computed tomography perfusion differences in mild cognitive impairment. J Neurol Neurosurg Psychiatry. 2007;78(3):240-7. (Pubitemid 46579659)
46. Caffarra P, Ghetti C, Concari L, Venneri A. Differential patterns of hypoperfusion in subtypes of mild cognitive impairment. Open Neuroimaging J. 2008;2:20-8.
47. Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, et al. Brain SPECT in subtypes of mild cognitive impairment. J Neurol. 2008;255(9):1344-53.
48. Busse A, Hensel A, Guhne U, Angermeyer M, Riedel-Heller S. Mild cognitive impairment: Long-Term course of four clinical subtypes. Neurology. 2006;67(12):2176-85. (Pubitemid 46035473)